OptiBiotix Health PLC OPTI
Trading Information
- Previous Close Price
- GBX4.40
- Day Range
- GBX4.40–4.50
- 52-Week Range
- GBX4.40–9.00
- Bid/Ask
- GBX0.00 / GBX0.00
- Shares Outstanding
- 103.30M
- Market Cap
- GBX454.52M
- Volume/Avg
- 2,971 / 172,328
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.51
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 9
- Website
- https://www.optibiotix.com
Valuation
Metric | OPTI |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.19 |
Price/Sales | 3.51 |
Price/Cash Flow | — |
Price/Earnings
OPTI
Financial Strength
Metric | OPTI |
|---|---|
Quick Ratio | 5.23 |
Current Ratio | 6.83 |
Interest Coverage | — |
Quick Ratio
OPTI
Profitability
Metric | OPTI |
|---|---|
Return on Assets (Normalized) | −32.99% |
Return on Equity (Normalized) | −42.47% |
Return on Invested Capital (Normalized) | −36.01% |
Return on Assets
OPTI
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|!W#Bx@ | LOCK|$K&K | $136B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|ZkZQ^KS | LOCK|#Fb#C | $99B | |||
| Moderna Inc MRNA | LOCK|F^VB##g | LOCK|<>@ | $87B | |||
| argenx SE ADR ARGX | LOCK|@>#<QD> | LOCK|dBg | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|z?@l&!j | LOCK|&L | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|jq<Y&kY | LOCK|czrM | $31B | |||
| Incyte Corp INCY | LOCK|wsZFH<M | LOCK|V$! | $25B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|czNc!l$ | LOCK|^X&rv | $21B | |||
| BioNTech SE ADR BNTX | LOCK|#!?!jn | LOCK|Mq | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|!gD<Mt | LOCK|%Q | $15B |